Adaptimmune Therapeutics
ADAP
#8446
Rank
A$0.24 B
Marketcap
$0.97
Share price
0.82%
Change (1 day)
31.45%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Net assets

Net assets on the balance sheet as of September 2024 : A$0.12 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has A$0.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Adaptimmune Therapeutics - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$57.99 M-51.8%
2022-12-31$A$0.12 B-57.65%
2021-12-31$A$0.28 B-35.98%
2020-12-31$A$0.44 B151.3%
2019-12-31$A$0.17 B-49.61%
2018-12-31$A$0.35 B34.79%
2017-12-31$A$0.26 B12.8%
2016-12-31$A$0.23 B
2015-06-30$A$0.33 B13090.18%
2014-06-30$A$2.55 M-208.51%
2013-06-30$-A$2.36 Million1822.42%
2012-06-30$-A$0.13 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-A$0.85 Billion-758.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$89.64 M-29.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$89.18 M-30.21%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$3.63 B 2,744.67%๐Ÿ‡บ๐Ÿ‡ธ USA